Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Chanteux
Effect of Rifampin on the Disposition of Brivaracetam in Human Subjects: Further Insights Into Brivaracetam Hydrolysis
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Related publications
Sulphuric Body Odor Under Therapy With Brivaracetam
Seizure : the journal of the British Epilepsy Association
Medicine
Neurology
Brivaracetam in the Treatment of Patients With Epilepsy—First Clinical Experiences
Frontiers in Neurology
Neurology
Further Insights Into the Anti-Aggregating Activity of NMDA in Human Platelets
British Journal of Pharmacology
Pharmacology
The Fate of Supernumerary Cryopreserved Embryos: Insights Into Couples' Disposition Decisions
Fertility and Sterility
Gynecology
Reproductive Medicine
Obstetrics
Pnd74 - Cost Utility Model of Brivaracetam in the Adjunctive Treatment for Partial-Onset Epileptic Seizures in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Insights Into the Cnx1E Catalyzed MPT-AMP Hydrolysis
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Further Insights Into the Chemistry of the Bi–U–O System
Dalton Transactions
Inorganic Chemistry
Brivaracetam as Adjunctive Therapy for the Treatment of Partial-Onset Seizures in Patients With Epilepsy: The Current Evidence Base
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Human Medicines European Public Assessment Report (EPAR): Briviact (In Italy: Nubriveo), Brivaracetam, Epilepsy, Date of Authorisation: 13/01/2016, Revision: 6, Status: Authorised
Case Medical Research
